Published Studies Related to Xopenex Inhalation (Levalbuterol Inhalation)
Well-designed clinical trials related to Xopenex Inhalation (Levalbuterol Inhalation)
A cumulative dose study of levalbuterol and racemic albuterol administered by hydrofluoroalkane-134a metered-dose inhaler in asthmatic subjects. [2008.09]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2008]
Long-term safety study of levalbuterol administered via metered-dose inhaler in patients with asthma. [2007.12]
An evaluation of levalbuterol HFA in the prevention of exercise-induced bronchospasm. [2007.11]
Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. [2007.01.25]
Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial. [2006.06]
A comparison of levalbuterol with racemic albuterol in the treatment of acute severe asthma exacerbations in adults. [2006.05]
Clinical efficacy of racemic albuterol versus levalbuterol for the treatment of acute pediatric asthma. [2005.07]
Comparison of levalbuterol and racemic albuterol combined with ipratropium bromide in acute pediatric asthma: a randomized controlled trial. [2005.07]
Pairwise comparison of levalbuterol versus racemic albuterol in the treatment of moderate-to-severe asthma. [2004.11]
An evaluation of nebulized levalbuterol in stable COPD. [2003.09]
The safety and efficacy of nebulized levalbuterol compared with racemic albuterol and placebo in the treatment of asthma in pediatric patients. [1999.04]
Well-designed clinical trials possibly related to Xopenex Inhalation (Levalbuterol Inhalation)
Comparison of physician-, biomarker-, and symptom-based strategies for adjustment
of inhaled corticosteroid therapy in adults with asthma: the BASALT randomized
controlled trial. [2012]
Hypertonic saline and acute wheezing in preschool children. [2012]
Helium-oxygen therapy for infants with bronchiolitis: a randomized controlled trial. [2011.12]
Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. [2011.09]
Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg/Arg patients with asthma. [2011.08]
Bronchodilator responsiveness and onset of effect with budesonide/formoterol pMDI in COPD. [2011.08]
Nebulized budesonide added to standard pediatric emergency department treatment of acute asthma: a randomized, double-blind trial. [2011.07]
Comparative efficacy of inhaled albuterol between two hand-held delivery devices in horses with recurrent airway obstruction. [2011.07]
Long-term safety and efficacy of indacaterol, a long-acting beta-agonist, in subjects with COPD: a randomized, placebo-controlled study. [2011.07]
Randomized controlled trial of a breath-actuated nebulizer in pediatric asthma patients in the emergency department. [2011.06]
Effect of bronchoconstriction on airway remodeling in asthma. [2011.05.26]
Omalizumab in severe allergic asthma inadequately controlled with standard therapy: a randomized trial. [2011.05.03]
Comparative lung bioavailability of fluticasone/salmeterol via a breath-actuated spacer and conventional plastic spacers. [2011.04]
Tiotropium versus salmeterol for the prevention of exacerbations of COPD. [2011.03.24]
The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. [2011.03.15]
Comparison of salbutamol efficacy in children--via the metered-dose inhaler (MDI) with Volumatic spacer and via the dry powder inhaler, Easyhaler, with the nebulizer--in mild to moderate asthma exacerbation: a multicenter, randomized study. [2011.03]
Randomized controlled trial to improve care for urban children with asthma: results of the School-Based Asthma Therapy trial. [2011.03]
Reported pneumonia in patients with COPD: findings from the INSPIRE study. [2011.03]
Efficacy and cost comparisons of bronchodilatator administration between metered dose inhalers with disposable spacers and nebulizers for acute asthma treatment. [2011.03]
Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial. [2011.02.19]
Lung function response to bronchodilator nebulization via hood in wheezy infants: a pilot study. [2011.01]
Bronchodilator efficacy and safety of indacaterol 150 mug once daily in patients with COPD: an analysis of pooled data. [2011]
Application of latent growth and growth mixture modeling to identify and
characterize differential responders to treatment for COPD. [2011]
The Beta Agonist Lung Injury TrIal (BALTI)--prevention trial protocol. [2011]
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma. [2010.12]
Combination therapy salmeterol/fluticasone versus doubling dose of fluticasone in children with asthma. [2010.11.15]
24-h bronchodilator efficacy of single doses of indacaterol in Japanese patients with asthma: a comparison with placebo and salmeterol. [2010.11]
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. [2010.10.28]
The effect of inhaled salmeterol, alone and in combination with fluticasone propionate, on management of COPD patients. [2010.10]
Usefulness of inhaled magnesium sulfate in the coadjuvant management of severe asthma crisis in an emergency department. [2010.10]
Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and fluticasone propionate in patients with persistent asthma. [2010.10]
Functional response to inhaled salbutamol and/or ipratropium bromide in Ascaris suum-sensitised cats with allergen-induced bronchospasms. [2010.10]
Comparable effect of a leukotriene receptor antagonist and long-acting beta-adrenergic agonist in cough variant asthma. [2010.09]
Reversibility of inspiratory lung function parameters after short-term bronchodilators in COPD. [2010.08.31]
Efficacy and safety of ipratropium bromide/albuterol delivered via Respimat inhaler versus MDI. [2010.08]
Bronchodilators accelerate the dynamics of muscle O2 delivery and utilisation during exercise in COPD. [2010.07]
Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma. [2010.07]
Plasma concentrations of salbutamol in the treatment of acute asthma in a pediatric emergency. Could age be a parameter of influence? [2010.06]
Systemic bioavailability of hydrofluoroalkane (HFA) formulations of fluticasone/salmeterol in healthy volunteers via pMDI alone and spacer. [2010.06]
Accuracy of death certificates in COPD: analysis from the TORCH trial. [2010.06]
Protective effect of budesonide/formoterol compared with formoterol, salbutamol and placebo on repeated provocations with inhaled AMP in patients with asthma: a randomised, double-blind, cross-over study. [2010.05.28]
Nebulized hypertonic saline/salbutamol solution treatment in hospitalized children with mild to moderate bronchiolitis. [2010.04]
Step-up therapy for children with uncontrolled asthma receiving inhaled corticosteroids. [2010.03.18]
Repeat dosing of albuterol via metered-dose inhaler in infants with acute obstructive airway disease: a randomized controlled safety trial. [2010.03]
Central and peripheral airway sites of nitric oxide gas exchange in COPD. [2010.03]
Is treatment with ICS and LABA cost-effective for COPD? Multinational economic analysis of the TORCH study. [2010.03]
Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. [2010.01]
High volume normal saline alone is as effective as nebulized salbutamol-normal saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. [2010.01]
Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study. [2010]
Effects of salmeterol on sleeping oxygen saturation in chronic obstructive pulmonary disease. [2010]
Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study. [2010]
Tiotropium bromide step-up therapy for adults with uncontrolled asthma. [2010]
Reversibility of inspiratory lung function parameters after short-term
bronchodilators in COPD. [2010]
Accuracy of death certificates in COPD: analysis from the TORCH trial. [2010]
Comparative effect of body mass index on response to asthma controller therapy. [2010]
Population pharmacokinetics and pharmacodynamics of inhaled ciclesonide and
fluticasone propionate in patients with persistent asthma. [2010]
High volume normal saline alone is as effective as nebulized salbutamol-normal
saline, epinephrine-normal saline, and 3% saline in mild bronchiolitis. [2010]
Additional effects of pranlukast in salmeterol/fluticasone combination therapy for the asthmatic distal airway in a randomized crossover study. [2009.12]
In vivo performance testing of the novel Medspray wet aerosol inhaler. [2009.12]
Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children. [2009.12]
Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial. [2009.11.21]
Methods for therapeutic trials in COPD: lessons from the TORCH trial. [2009.11]
Adherence to inhaled therapy, mortality and hospital admission in COPD. [2009.11]
Beneficial effects of warmed humidified oxygen combined with nebulized albuterol and ipratropium in pediatric patients with acute exacerbation of asthma in winter months. [2009.11]
Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED). [2009.11]
The bioavailability and airway clearance of the steroid component of budesonide/formoterol and salmeterol/fluticasone after inhaled administration in patients with COPD and healthy subjects: a randomized controlled trial. [2009.10.31]
Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. [2009.10.20]
Effect of fluticasone propionate/salmeterol (250/50) on COPD exacerbations and impact on patient outcomes. [2009.10]
Does parental involvement in pediatric emergency department asthma treatment affect home management? [2009.10]
Regular vs prn nebulized treatment in wheeze preschool children. [2009.10]
Interaction of ambient air pollution with asthma medication on exhaled nitric oxide among asthmatics. [2009.09]
Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. [2009.09]
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. [2009.08.29]
Bronchodilator effects of exercise hyperpnea and albuterol in mild-to-moderate asthma. [2009.08]
A novel breath-actuated integrated vortex spacer device increases relative lung bioavailability of fluticasone/salmeterol in combination. [2009.08]
Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD. [2009.08]
Predictors of poor response during asthma therapy differ with definition of outcome. [2009.08]
Comparative efficacy of combined nebulized salbutamol with ipratropium bromide and nebulized adrenaline to treat children with acute bronchiolitis. [2009.07]
Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial. [2009.06.18]
Efficacy and safety evaluation of ciclesonide in subjects with mild-to-moderate asthma not currently using inhaled corticosteroids. [2009.05]
Efficacy and safety evaluation of ciclesonide in mild-to-moderate persistent asthma previously treated with inhaled corticosteroids. [2009.05]
Effect of the inhaled corticosteroid mometasone on small airway patency in patients with asthma. [2009.05]
Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma. [2009.05]
High-dose inhaled flunisolide versus budesonide in the treatment of acute asthma exacerbations in preschool-age children. [2009.04]
Effects of fluticasone propionate and salmeterol hydrofluoroalkane inhalation aerosol on asthma-related quality of life. [2009.04]
Short-term effects of inhaled salbutamol on autonomic cardiovascular control in healthy subjects: a placebo-controlled study. [2009.04]
Anti-inflammatory effects of salmeterol/fluticasone, tiotropium/fluticasone or tiotropium in COPD. [2009.04]
Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD. [2009.04]
Modulation of operational lung volumes with the use of salbutamol in COPD patients accomplishing upper limbs exercise tests. [2009.02]
|